Category Archive: Finance

Hormel Foods Dividend Stock Analysis: Beefing Up Earnings

Hormel Foods Dividend Stock Analysis: Beefing Up Earnings

Hormel Foods (HRL) released its 2nd quarter 2015 results this morning. The company reported earnings-per-share of $0.67 per share for the quarter. Earnings-per-share rose 29% from $0.52 per share in the same quarter a year ago. The market has responded favorably, pushing the company’s share price up over 4% at the time of this writing. Hormel’s Growth Explored […]
San Francisco – No Bubble Here

San Francisco – No Bubble Here

The charts below certainly reflect a rational free market trend. Right? Home prices always double in the space of three years when the economy is limping along with sub 2% GDP growth and median real household income is still 7% below the levels of 2007 and equal to levels of 1989. These are the median […]
Asset Bubble Deleveraging

Asset Bubble Deleveraging

Guest post By Alhambra Investment Partners We Are Going To Find Out If An Immense Asset Bubble Can Be Carefully And Purposefully Deleveraged Some people are getting very nervous about China, and as usual that stems from a misreading of the Chinese intentions. This is not to say that one should not be concerned at all, […]
EUR/USD Falls During The Tuesday Session

EUR/USD Falls During The Tuesday Session

The EUR/USD pair fell rather hard during the session on Tuesday, testing the 1.1150 level. With that, it appears that the market is going to try to find buyers between here and the 1.10 level, and as a result I am actually waiting for a supportive candle in order to go long. I think we […]
Productivity And Economic Growth

Productivity And Economic Growth

Productivity is the most important determinant of the standard of living  of a group of people, a nation or a planet. Productivity in its simplest form is output per hour worked, and its recent slower growth rate is distressing. This article summarizes why productivity is crucial to our standard of living. The next article explains its […]
Bull Of The Day: Cisco Systems, Inc.

Bull Of The Day: Cisco Systems, Inc.

In mid-April, I recommended buying Cisco (CSCO – Analyst Report) at $28 as one of my top picks to capitalize on the major technology trend known as The Internet of Things. Now that the stock has been bumped up to a Zacks #1 Rank Strong Buy, I’m still a fan of “the architect” of the worldwide web. Here was […]
Crude Tumbles Despite 3rd Weekly Inventory Draw & Production Plunge

Crude Tumbles Despite 3rd Weekly Inventory Draw & Production Plunge

Following last night’s 5.2 million barrel inventory draw reported by API, crude prices surged once again (bouncing off levels before the first inventory draw at the end of April). Consensus appears confused since Bloomberg median estimates were for a 1.75mm draw while survey respondents expected a 3.82 million barrel draw this morning. DOE data showed a disappointly […]
Lowe’s Q1 Earnings & Revenues Miss Estimates

Lowe’s Q1 Earnings & Revenues Miss Estimates

Lowe’s Companies Inc. (LOW – Analyst Report), one of the largest home improvement retailers, came out with first-quarter fiscal 2015 results, wherein earnings of 70 cents a share missed the Zacks Consensus Estimate of 74 cents but jumped 14.8% year over year. Management now envisions earnings of approximately $3.29 per share for fiscal 2015. The current Zacks […]
“Sell In May And Go Away” Might Be A Good Idea For Conventional Assets

“Sell In May And Go Away” Might Be A Good Idea For Conventional Assets

Volatility in the currency markets, bond markets, and stock markets likely has a lot of people on Wall Street feeling a bit worn out. Taking a summer vacation in the Hamptons might just be their best idea. The coming months promise to be anything but quiet and predictable. Here are a couple of items that […]
Intercept Pharmaceuticals Inc. Moves Forward With OCA ‘Regenerate’ Trial

Intercept Pharmaceuticals Inc. Moves Forward With OCA ‘Regenerate’ Trial

On May 19, Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) announced plans for an international Phase 3 trial of OCA in patients with NASH.  Intercept is developing obeticholic acid, or OCA, for patients with nonalcoholic steatohepatitis, or NASH. Patients with NASH often have abnormal liver function due to a fatty liver or inflammation. OCA has already received breakthrough […]